Liquidia Corporation (NASDAQ:LQDA) Stock Has Average Target Price of $72.85 According to Analysts

Shares of Liquidia Corporation (NASDAQ:LQDA) have received a consensus recommendation of “Hold” from the twelve analysts that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $72.85.

A number of brokerages recently commented on LQDA. Wedbush set a $58.00 price target on shares of Liquidia in a research note on Friday, October 2nd. Zacks Research downgraded shares of Liquidia from a “hold” rating to a “strong sell” rating in a research report on Tuesday, September 22nd. Royal Bank Of Canada set a $65.00 price objective on shares of Liquidia in a research report on Thursday, October 15th. Wells Fargo & Company boosted their price objective on Liquidia from $30.00 to $33.00 and gave the stock an “equal weight” rating in a report on Wednesday, October 14th. Finally, Piper Sandler set a $129.00 target price on Liquidia in a research report on Friday, July 24th.

Insider Buying and Selling at Liquidia

In related news, insider Sarah Krepp sold 5,245 shares of the business’s stock in a transaction on Monday, October 12th. The stock was sold at an average price of $28.48, for a total value of $149,377.60. Following the completion of the sale, the insider directly owned 115,241 shares in the company, valued at $3,282,063.68. The trade was a 4.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Sanjeev Khindri sold 1,101 shares of the company’s stock in a transaction on Monday, October 12th. The shares were sold at an average price of $28.48, for a total value of $31,356.48. Following the completion of the transaction, the insider directly owned 64,846 shares in the company, valued at approximately $1,846,814.08. This represents a 1.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 564,310 shares of company stock worth $25,648,122 in the last 90 days. Company insiders own 25.60% of the company’s stock.

Institutional Investors Weigh In On Liquidia

Institutional investors have recently modified their holdings of the business. Bank of America Corp DE increased its position in Liquidia by 18.7% during the first quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock worth $86,341,000 after acquiring an additional 360,372 shares during the period. Eversept Partners LP boosted its holdings in Liquidia by 33.0% in the 1st quarter. Eversept Partners LP now owns 677,392 shares of the company’s stock valued at $25,565,000 after purchasing an additional 167,949 shares during the period. Pale Fire Capital SE boosted its holdings in Liquidia by 2.4% in the 1st quarter. Pale Fire Capital SE now owns 388,377 shares of the company’s stock valued at $14,657,000 after purchasing an additional 8,985 shares during the period. Bank of New York Mellon Corp bought a new stake in Liquidia in the 2nd quarter valued at about $29,694,000. Finally, Seven Fleet Capital Management LP grew its position in shares of Liquidia by 25.2% during the 2nd quarter. Seven Fleet Capital Management LP now owns 256,603 shares of the company’s stock worth $20,459,000 after purchasing an additional 51,727 shares in the last quarter. Institutional investors own 64.54% of the company’s stock.

Liquidia Stock Performance

Shares of Liquidia stock opened at $42.65 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12. The business has a fifty day simple moving average of $55.83 and a two-hundred day simple moving average of $61.75. Liquidia has a 1 year low of $22.05 and a 1 year high of $93.61. The company has a market capitalization of $3.82 billion, a price-to-earnings ratio of 31.13, a P/E/G ratio of 0.37 and a beta of 0.61.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings data on Wednesday, August 12th. The company reported $0.74 EPS for the quarter, missing the consensus estimate of $0.76 by ($0.02). The company had revenue of $171.68 million during the quarter, compared to analyst estimates of $168.48 million. Liquidia had a net margin of 30.74% and a return on equity of 149.65%. Liquidia’s revenue for the quarter was up 1842.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.49) earnings per share. Research analysts forecast that Liquidia will post 2.05 EPS for the current year.

Liquidia Company Profile

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.

Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.